Integrated Filing — IndAS



General information about company
Scrip Code 543389
NSE Symbol SIGACHI
MSEI Symbol NOTLISTED
ISIN INE0D0K01022
Name of company SIGACHI INDUSTRIES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 30-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 22-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 30-May-2025   12:00:00
End date and time of board meeting 30-May-2025   15:50:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-05-30
Indicate Company website link for updated RPT policy of the Company https://sigachi.com/Policies/POLICY%20ON%20RELATED%20PARTY%20TRANSACTIONS%20AND%20ITS%20MATERIALITY.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Nodefault



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 1135405000 4078330000
Other income 17719000 200772000
Total income 1153124000 4279102000
2 Expenses
(a) Cost of materials consumed 566357000 1916692000
(b) Purchases of stock-in-trade -16095000 60451000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 5076000 -26991000
(d) Employee benefit expense 153345000 575487000
(e) Finance costs 28008000 106570000
(f) Depreciation, depletion and amortisation expense 39414000 129219000
(f) Other Expenses
1 Manufacturing Expenses 85529000 352826000
2 Insurance 6113000 29156000
3 Selling Expenses 24925000 59865000
4 Travelling and Conveyance 32285000 55391000
5 Professional and Consultancy Fees 19816000 52815000
6 Carriage Outward 24835000 182842000
7 CSR 3664000 10230000
8 Communication Expenses 1368000 6924000
9 Other Expenses 41245000 60025000
Total other expenses 239780000 810074000
Total expenses 1015885000 3571502000
3 Total profit before exceptional items and tax 137239000 707600000
4 Exceptional items 0 0
5 Total profit before tax 137239000 707600000
6 Tax expense
7 Current tax 34165000 125742000
8 Deferred tax 33296000 105184000
9 Total tax expenses 67461000 230926000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 69778000 476674000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 69778000 476674000
17 Other comprehensive income net of taxes -4009000 -3124000
18 Total Comprehensive Income for the period 65769000 473550000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 382117000 382117000
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 5214853000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.18 1.41
Diluted earnings (loss) per share from continuing operations 0.21 1.41
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.18 1.41
Diluted earnings (loss) per share from continuing and discontinued operations 0.21 1.41
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results
Textual Information(1) Theaboveauditedstandalonefinancialresultsforthequarterandyearended31March2025havebeenreviewedbythe AuditCommitteeandapprovedbytheBoardofDirectorsoftheCompanyattheirrespectivemeetingsheldon30May2025 n nCompanyhavesinglereportingsegmentPhramaceuticals n



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 2259783000
Capital work-in-progress 48727000
Investment property 0
Goodwill 0
Other intangible assets 12766000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 1018465000
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 583258000
Total non-current financial assets 1601723000
Deferred tax assets (net) 0
Other non-current assets 393084000
Total non-current assets 4316083000
2 Current assets
Inventories 381012000
Current financial asset
Current investments 0
Trade receivables, current 1341815000
Cash and cash equivalents 94678000
Bank balance other than cash and cash equivalents 547355000
Loans, current 0
Other current financial assets 639074000
Total current financial assets 2622922000
Current tax assets (net) 0
Other current assets 139683000
Total current assets 3143617000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 7459700000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 382117000
Other equity 5214482000
Total equity attributable to owners of parent 5596599000
Non controlling interest
Total equity 5596599000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 216143000
Total non-current financial liabilities 216143000
Provisions, non-current 25608000
Deferred tax liabilities (net) 188020000
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities 429771000
Current liabilities
Current financial liabilities
Borrowings, current 885104000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 9263000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 317766000
Total Trade payable 327029000
Other current financial liabilities 24956000
Total current financial liabilities 1237089000
Other current liabilities 189348000
Provisions, current 0
Current tax liabilities (Net) 6893000
Deferred government grants, Current 0
Total current liabilities 1433330000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 1863101000
Total equity and liabilites 7459700000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit or loss -6162000 -4802000
Total Amount of items that will not be reclassified to profit and loss -6162000 -4802000
2 Income tax relating to items that will not be reclassified to profit or loss -2153000 -1678000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income -4009000 -3124000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 707600000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 106570000
Adjustments for decrease (increase) in inventories -71755000
Adjustments for decrease (increase) in trade receivables, current -245745000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -38177000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 51969000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 25890000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 129219000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 0
Adjustments for provisions, non-current -4802000
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 44878000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow -120927000
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -212636000
Net cash flows from (used in) operations 494964000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 138791000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 356173000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 70953000
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 415379000
Proceeds from sales of investment property 0
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 44878000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -461640000
Net cash flows from (used in) investing activities -903094000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 1055523000
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 220878000
Payments of lease liabilities -807000
Dividends paid 32819000
Interest paid 106570000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 74000
Net cash flows from (used in) financing activities 696137000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 149216000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 149216000
Cash and cash equivalents cash flow statement at beginning of period 492818000
Cash and cash equivalents cash flow statement at end of period 642034000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Yelamanchi & Associates Yes 30-Sep-2025


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)
Mode of Fund Raising Preferential Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 08-Feb-2025
Amount Raised 952713000
Report filed for Quarter ended 31-Mar-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable Care Edge
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation Nil
Comments of the Audit Committee after review Nil
Comments of the auditors, if any Nil
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any


Signatory Details
Name of signatory Vivek Kumar
Designation of person Company Secretary and Compliance Officer
Place Hyderabad
Date 30-May-2025




Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Sigachi Industries Limited Ravindra Prasad Sinha Director Remuneration Approved 3360000 6963000 560000
2 Sigachi Industries Limited S.Chidambaranathan Director Remuneration Approved 3360000 480000 560000
3 Sigachi Industries Limited Amit Raj Sinha Managing Director and CEO Remuneration Approved 8200000 671000 1400000
4 Sigachi Industries Limited Sarveswar Reddy Sanivarapu Director Any other transaction Sitting Fees Approved 140000 0 0
5 Sigachi Industries Limited Dhanalakshmi Guntaka Director Any other transaction Sitting Fees Approved 340000 0 0
6 Sigachi Industries Limited Bindu Vinodhan Director Any other transaction Sitting Fees Approved 290000 0 0
7 Sigachi Industries Limited Janardhan Reddy Y Director Any other transaction Sitting Fees Approved 330000 0 0
8 Sigachi Industries Limited Amit Raj Sinha Managing Director and CEO Any other transaction Rent Approved 1051000 175000 175000
9 Sigachi Industries Limited RPS Industries Private Limited Entity Controlled by KMP Any other transaction Lease Rentals Approved 16148000 0 2691000
10 Sigachi Industries Limited Sigachi US INC Wholly Owned Subsidiary Sale of goods or services Approved 179874000 94586000 222099000
11 Sigachi Industries Limited Sigachi MENA FZCO Wholly Owned Subsidiary Sale of goods or services Approved 94940000 82951000 168318000
12 Sigachi Industries Limited Trimax Bio Sciences Private Limited Subsidiary Purchase of goods or services Approved 14429000 357797000 372226000
13 Sigachi Industries Limited Swati Sinha Wife of Director Remuneration Approved 1350000 0 225000
Total value of transaction during the reporting period 323812000